Prestige Consumer Healthcare Inc. (PBH) Moves Lower on Volume Spike for February 05

Equities Staff  |

Prestige Consumer Healthcare Inc. (PBH) traded on unusually high volume on Feb. 05, as the stock lost 0.14% to close at $28.22. On the day, Prestige Consumer Healthcare Inc. saw 1.04 million shares trade hands on 4,880 trades. Considering that the stock averages only a daily volume of 578,110 shares a day over the last month, this represents a pretty significant bump in volume over the norm.

Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.

The stock has traded between $41.76 and $26.25 over the last 52-weeks, its 50-day SMA is now $32.03, and its 200-day SMA $35.36. Prestige Consumer Healthcare Inc. has a P/B ratio of 1.22. It also has a P/E ratio of 4.3.

Prestige Consumer Healthcare Inc, formerly Prestige Brands distributes branded over-the-counter healthcare and household cleaning products to mass merchandisers, drug stores, convenience stores, and supermarkets. The firm's major brands include Chloraseptic, Clear Eyes, Compound W, Dramamine, and Comet. Prestige Brands operates in three segments: North American over-the-counter, or OTC healthcare; international over-the-counter healthcare; and household cleaning. The North American OTC segment generates the vast majority of revenue. The largest product groups in the OTC healthcare segments include analgesics, cough and cold, gastrointestinal, and women's health. It has customers in the United States, Canada, and Australia. Sales within the United States contribute the majority of revenue.

Headquartered in Tarrytown, NY, Prestige Consumer Healthcare Inc. has 530 employees and is currently under the leadership of CEO Ronald Lombardi.

For a complete fundamental analysis analysis of Prestige Consumer Healthcare Inc., check out’s Stock Valuation Analysis report for PBH.

Still paying commissions on stock trades? now offers 100% commission free stock trading and flat-fee options trading for $89.95/month! Get started today by

To get more information on Prestige Consumer Healthcare Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: PBH’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change





















Humanity. 2.0 - Opening Address at the Vatican

The opening address was delivered by Rev. Philip Larrey, Chairman of. Humanity 2.0, and Matthew. Sanders, CEO & Founder of Humanity 2.0.